Letter to the Editor
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia
¿Por qué elegir ciclosporina A como primera línea terapéutica para la neumonía causada por COVID-19?
Read
775
Timeswas read the article
37
Total PDF
692
Total HTML
46
Total EPUB
| Year/Month | Html | Epub | Total | |
|---|---|---|---|---|
| 2022 May | 52 | 21 | 42 | 115 |
| 2022 April | 54 | 2 | 1 | 57 |
| 2022 March | 56 | 2 | 1 | 59 |
| 2022 February | 55 | 2 | 1 | 58 |
| 2022 January | 220 | 2 | 0 | 222 |
| 2021 December | 203 | 4 | 1 | 208 |
| 2021 November | 52 | 4 | 0 | 56 |
| 2021 October | 0 | 0 | 0 | 0 |
